Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Chemical modification or the reaction product thereof – e.g.,...
Reexamination Certificate
2007-01-23
2007-01-23
Minnifield, Nita (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Chemical modification or the reaction product thereof, e.g.,...
C530S403000, C530S404000, C530S405000, C530S406000, C530S407000, C530S408000, C530S409000, C530S410000, C530S411000, C530S412000, C530S414000, C530S391900, C530S810000, C424S236100, C424S194100, C424S184100
Reexamination Certificate
active
10650786
ABSTRACT:
This invention relates to a process for preparing a hapten-protein-polysaccharide conjugate and a hapten-protein conjugate by reacting a protein with a hapten to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide to provide a conjugate mixture including the hapten-protein conjugate and a hapten-protein-polysaccharide conjugate. This invention also includes the process described above with the addition of a pharmaceutically acceptable medium or delivery vehicle into the conjugate mixture. The invention further includes the process described above where the hapten is luteinizing hormone releasing hormone peptides derived fromE coil, or malaria derived peptides.
REFERENCES:
patent: 5302386 (1994-04-01), Kasper et al.
patent: 5585100 (1996-12-01), Mond et al.
patent: 5651971 (1997-07-01), Lees
patent: 5693326 (1997-12-01), Lees
patent: 5849301 (1998-12-01), Lees
patent: 5874085 (1999-02-01), Mond et al.
patent: 5955079 (1999-09-01), Mond et al.
patent: 6087328 (2000-07-01), Lees
patent: 6146902 (2000-11-01), McMaster
patent: 6149911 (2000-11-01), Binz et al.
patent: 6224880 (2001-05-01), Chan et al.
patent: 6248334 (2001-06-01), Lees et al.
patent: 6284250 (2001-09-01), Lees et al.
patent: 6299881 (2001-10-01), Lees et al.
patent: 6309646 (2001-10-01), Lees
patent: 6361777 (2002-03-01), Hoogerhout
patent: 6585973 (2003-07-01), Lees
patent: 6673905 (2004-01-01), Pozsgay
patent: 6756041 (2004-06-01), Lees et al.
patent: 7101562 (2006-09-01), Lees et al.
patent: 2005/0074460 (2005-04-01), Lees et al.
patent: 2005/0271675 (2005-12-01), Schneerson et al.
patent: 21719742 (1995-03-01), None
patent: 0378881 (1990-07-01), None
patent: WO 86/01228 (1986-02-01), None
patent: WO 92/00101 (1992-01-01), None
patent: WO 96 29094 (1996-09-01), None
patent: WO 96 40242 (1996-12-01), None
patent: WO 98 30239 (1998-07-01), None
patent: WO 98/58670 (1998-12-01), None
patent: WO 99/12416 (1999-03-01), None
patent: WO 99/52548 (1999-10-01), None
patent: WO 99/64603 (1999-12-01), None
patent: WO 2005/072778 (2005-08-01), None
Saksena et al, Tetrahedron: Asymmetry, 2005, 16:187-197.
Carmenate et al, FEMS Immunology and Medical Microbiology, 2004, 40:193-199.
Mieszala et al, Carbohydrate Research, 2003, 338:167-175.
Saksena et al, Methods in Enzymology, 2003, 362:125-139.
Saksena et al, Methods in Enzymology, 2003, 362:140-159.
Ragupathi et al, Vaccine 2002, 20:1030-1038.
Libon et al, Vaccine, 2002, 20:2174-2180.
Maitta et al, Infection and Immunity, Jan. 2004, 72/1:196-208.
Klaus et al, European J. Immunology, 1974, 4/7:505-511.
Makela et al, Annales d'immunologie, Jul.-Aug. 1983, 134D/1:25-36.
Romano et al, european J. Immunology, Jun. 1976, 6/6:434-442.
Seppala et al, Immunology, Dec. 1984, 53/4:827-836.
Svenson et al, J. Immunological Methods, 1979, 25/4:323-335.
Lees et al, Vaccine, 2006, 24:716-729.
Peeters et al., “Pneumococcal Conjugate Vaccines,” Immunology Letters, vol. 30, No. 2, 1991, pp. 267-274.
Cassels et al., Abstract, “Antibody to N-Terminal Consensus Peptide is Cross-Reactive with all Six Members of the EnterotoxigenicE. coliCFA/I Family,” 31stJoint Conference, U.S./Japan Cooperative Medical Sciences Program Panels on Malnutrition and Cholera, Kiawah Island, South Caroling, Dec. 1, 1995.
Halista et al., Pediatric Research 43/4:496-503, 1998.
Akkoyunlu et al., “Biological Activity of Serum Antibodies to a Nonacylated Form of Lipoprotein D ofHaemophilus influenzae,” Infection & Immunity, vol. 64, 1996, pp. 4586-4592.
Lees et al., “Activation of Soluble Polysaccharides with 1-Cyano-4-Dimethylamino Pyridinium Tetrafluoroborate for Use in Protein-Polysaccharide Conjugate Vaccines and Immunological Reagents,” Vaccine, vol. 14, No. 3, 1996, pp. 190-198.
Ellis et al. (Editors), Development and Clinical Uses of Haemophilus B. Conjugate Vaccines, Marcel Dekker, New York, 1994.
Lees et al., “Enhanced Immunogenicity of Protein-Dextran Conjugates: I. Rapid Stimulation of Enhanced Antibody Responses to Poorly Immunogenic Molecules,” Vaccine, vol. 12, No. 13, 1994, pp. 1160-1166.
Martin, E.W., Remington's Pharmaceutical Sciences, 18thEdition, 1994, pp. 1435-1711, 1389-1404.
Cruse et al. (Editors), Conjugate Vaccines, Karger, Basel, 1989.
Dick et al., “Glyconjugates of Bacterial Carbohydrates Antigens: A Survey and Consideration of Design and Preparation Factors,” Conjugate Vaccines (Eds. Cruse et al.), Karger, Basel, 1989, pp. 48-114.
Monsigny et al., “Colorimetric Determination of Neutral Sugars by a Resorcinol Sulfuric Acid Micromethod,” Anal. Biochem. vol. 175, 1988, pp. 525-530.
Vidal & Franci, Letter to the Editors, J. Immunol. Meth., vol. 86, 1986, pp. 155-156.
Lamb et al., J. O Chromotography, 2000, 894:311-318.
Pawlowski et al., Vaccine, 2000, 18:1873-1885.
Pawlowski et al., Vaccine, 1999, 17:1474-1483.
Shafer et al., Vaccine, 2001, 19:1547-1558.
Meacle et al., J. of Membrane Science, 1999, 161:171-184.
Lees Andrew
Mond James
Biosynexus, Inc.
Finnegan Henderson Farabow Garrett & Dunner LLP
Minnifield Nita
LandOfFree
Process for preparing conjugate vaccines and the conjugate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing conjugate vaccines and the conjugate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing conjugate vaccines and the conjugate... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3763414